Browse by author
Lookup NU author(s): Dr Nicholas Hoenich
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Treatment of renal failure by haemodialysis uses dialysis fluid to facilitate the normalization of electrolyte and acid base abnormalities and the removal of low molecular weight uraemic compounds present in the plasma such as urea. The dialysis fluid is a continuously produced blend of treated tap water and a concentrated solution containing electrolytes, buffer, and glucose. The water used originates as drinking water but undergoes additional treatment. Recent surveys have indicated that the chemical and microbiological content of such water frequently fails to meet the requirements of established standards, and its bacterial content arising from the presence of a biofilm in the water distribution network or the hydraulic circuit of the dialysis machine is a contributory factor to the chronic inflammatory state in patients undergoing regular dialysis. The composition of the dialysis fluid plays an important role in the modulation of complications associated with end-stage renal disease, as well as those associated with the treatment itself. The avoidance of complications arising from water contaminants requires a constant and vigorous attention to water quality, whilst with the composition of electrolytes and buffer there is a trend towards greater individualization to provide a high degree of treatment tolerance. Copyright © 2006 S. Karger AG.
Author(s): Hoenich NA, Ronco C, Levin R
Publication type: Article
Publication status: Published
Journal: Blood Purification
Year: 2006
Volume: 24
Issue: 1
Pages: 11-18
ISSN (print): 0253-5068
ISSN (electronic): 1421-9735
Publisher: S. Karger AG
URL: http://dx.doi.org/10.1159/000089430
DOI: 10.1159/000089430
PubMed id: 16361834
Altmetrics provided by Altmetric
